Provided by Tiger Fintech (Singapore) Pte. Ltd.

EUDA Health Holdings Limited

3.89
+0.630019.33%
Post-market: 3.930.0400+1.03%19:48 EDT
Volume:105.80K
Turnover:375.57K
Market Cap:144.54M
PE:537.59
High:3.94
Open:3.32
Low:3.30
Close:3.26
52wk High:6.30
52wk Low:1.03
Shares:37.16M
Float Shares:18.40M
Volume Ratio:1.21
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0072
EPS(LYR):-0.4731
ROE:--
ROA:-63.92%
PB:-38.96
PE(LYR):-8.22

Loading ...

EUDA Health Holdings Amends Convertible Note Agreement

TIPRANKS
·
Oct 04

EUDA Health Holdings Reports Revenue Growth in H1 2025

TIPRANKS
·
Oct 02

Euda Health Holdings Subsidiary Reports Sharp Decrease in Net Loss and Improved EPS for H1 2025

Reuters
·
Oct 02

Greenridge Global Sticks to Its Buy Rating for EUDA Health Holdings (EUDA)

TIPRANKS
·
Sep 24

Euda Health Holdings Ltd. Announces Conversion of Shares and Debt Repayment Agreement with Indigo Capital

Reuters
·
Sep 23

EUDA Health Holdings Explores Acquisition of GO POSB to Expand iPSC Solutions

TIPRANKS
·
Sep 11

EUDA Health Holdings Ltd. Signs Letter of Intent to Acquire Singapore-Based Biotechnology Firm GO POSB

Reuters
·
Sep 10

EUDA Health Holdings Ltd - Facility to Distribute Ipsc Solutions Across China

THOMSON REUTERS
·
Sep 10

EUDA Signs Letter of Intent to Potentially Acquire Go Posb

THOMSON REUTERS
·
Sep 10

EUDA Health Holdings- Co & Go Posb to Explore to Establish Induced Pluripotent Stem Cell Facility in Shenzhen

THOMSON REUTERS
·
Sep 10

EUDA Health Holdings Ltd - T-Cell Immunotherapy Package to Retail at USD 8,000 per Treatment

THOMSON REUTERS
·
Sep 04

EUDA Health Holdings Ltd - Secures Distribution Rights for T-Cell Immunotherapies in Malaysia Developed by Shenzhen Inno Immune Co. Ltd

THOMSON REUTERS
·
Sep 04

EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio

GlobeNewswire
·
Sep 04

EUDA Health to Conduct Due Diligence on Potential Acquisition of Chemokine; Shares Up Pre-Bell

MT Newswires Live
·
Aug 28

BRIEF-EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte

Reuters
·
Aug 28

EUDA Health Holdings Ltd - Chemokine Agrees to 120-Day Exclusivity for EUDA Acquisition

THOMSON REUTERS
·
Aug 28

EUDA Health Holdings Ltd - Unit Secures Exclusive Worldwide Distribution Rights for a Immune Health Supplement From Chemokine

THOMSON REUTERS
·
Aug 27

Euda Health Secures Exclusive Global Distribution Rights for Next-Gen Immune Supplement

Reuters
·
Aug 26

Euda Health Holdings Ltd. Files Prospectus for $10 Million At-The-Market Offering of Ordinary Shares

Reuters
·
Jun 24

EUDA Health Holdings Ltd. Announces Departure of COO John Ang Bian Guan, Effective June 3, 2025

Reuters
·
Jun 02